Risk of Stillbirth after Infertility Treatment in the United States: 2014-2017

Authors

  • Deepa Dongarwar Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine, Houston, Texas, USA
  • Hamisu Mohammed Salihu Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA

DOI:

https://doi.org/10.21106/ijma.345

Keywords:

  • ART,
  • Infertility treatment,
  • Fertility enhancing drugs,
  • Stillbirth in US

Abstract

To estimate the risk of stillbirth following infertility treatment in the United States (US), we analyzed data from the US Natality and Fetal Death files from 2014 to 2017. We built Cox proportional regression models to generate adjusted hazard ratios (HR) for the risk of stillbirth among women who utilized various modalities of infertility treatment within the study period. Women who used any infertility treatment and, specifically, assisted reproductive technology (ART), had an elevated risk of stillbirth (HR: 1.21, 95% CI:1.09 -1.33) compared to women who did not use ART. We concluded that in this population, the risk of stillbirth was elevated among women using infertility treatment.

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 3 > >> 

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Downloads

Abstract Views: 2577
PDF Views/Downloads: 310
HTML Views/Downloads: 72

Published

2020-02-22
Dimensions Citation count:

How to Cite

Dongarwar, D., & Salihu, H. M. (2020). Risk of Stillbirth after Infertility Treatment in the United States: 2014-2017. International Journal of Maternal and Child Health and AIDS, 9(1), 149–152. https://doi.org/10.21106/ijma.345

License


Copyright © 2020 Deepa Dongarwar, Hamisu Mohammed Salihu. Published by Global Health and Education Projects, Inc., USA.

Creative Commons License

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , which permits others to remix, transform, and build upon the work non-commercially, provided the original author is credited and the new creations are licensed under the same terms.